RECURRENT SOLID TUMOR

Clinical trials for RECURRENT SOLID TUMOR explained in plain language.

Never miss a new study

Get alerted when new RECURRENT SOLID TUMOR trials appear

Sign up with your email to follow new studies for RECURRENT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

New drug targets Hard-to-Treat cancers in early trial

Disease control Ongoing

This early-phase study tests a new drug called LY4101174 in people with advanced or metastatic solid tumors, including bladder, breast, lung, and other cancers. The goal is to find a safe and effective dose and see if the drug can shrink tumors. About 490 participants will take p…

Matched conditions: RECURRENT SOLID TUMOR

Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated May 05, 2026 11:52 UTC

RECURRENT SOLID TUMOR

Get alerted when new RECURRENT SOLID TUMOR trials appear

New drug targets Hard-to-Treat cancers in early trial